SABR
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SABR, covering 2017-05-23 to 2020-11-12. Get the full timeline:
Most recent: Clinical Trial Update: Anti-PD-L1 and SAbR for Ovarian Cancer [Phase 2]
2 regulatory and trial events tracked for SABR, covering 2017-05-23 to 2020-11-12. Get the full timeline:
Most recent: Clinical Trial Update: Anti-PD-L1 and SAbR for Ovarian Cancer [Phase 2]